Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Elite Pharmaceuticals Inc

+ Add to Watchlist

ELTP:US

0.2450 USD 0.0090 3.81%

As of 20:10:00 ET on 03/31/2015.

Snapshot for Elite Pharmaceuticals Inc (ELTP)

Open: 0.2430 Day's Range: 0.2300 - 0.2450 Volume: 1,072,415
Previous Close: 0.2360 52wk Range: 0.1745 - 0.5100 1-Yr Rtn: -40.24%

Stock Chart for ELTP

No chart data available.
  • ELTP:US 0.2450
  • 1D
  • 1M
  • 1Y
0.2360
Interactive ELTP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ELTP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1746
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 151.51
Shares Outstanding (M) 618.41
30 Day Average Volume 1,586,286
Price/Book (mrq) -
Price/Sale (ttm) 29.0842
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ELTP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ELTP

Elite Pharmaceuticals, Inc. researches, develops, licenses, and manufactures both new and generic oral controlled-release pharmaceutical products. The Company has pain products in clinical trials and has developed products incorporating therapeutic agents such as cardiovasculars, antidiabetic, cough and cold preparations, and anti-infectives.

Nasrat HakimPresident/CEOCarter J WardCFO/Secretary/Treasurer
Ashok G NigalayeChief Scientific Officer
More Company Profile & Key Executives for ELTP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil